Related references
Note: Only part of the references are listed.Neuronal-Targeted TFEB Accelerates Lysosomal Degradation of APP, Reducing Aβ Generation and Amyloid Plaque Pathogenesis
Qingli Xiao et al.
JOURNAL OF NEUROSCIENCE (2015)
Increased Alzheimer's disease-like pathology in the APP/PS1ΔE9 mouse model lacking Nrf2 through modulation of autophagy
Gururaj Joshi et al.
NEUROBIOLOGY OF AGING (2015)
BAG3 facilitates the clearance of endogenous tau in primary neurons
Zhinian Lei et al.
NEUROBIOLOGY OF AGING (2015)
SUMO1 promotes Aβ production via the modulation of autophagy
Sun-Jung Cho et al.
AUTOPHAGY (2015)
Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in Alzheimer's disease transgenic mice
Antonio Currais et al.
AGING CELL (2014)
Fisetin inhibits human melanoma cell growth through direct binding to p70S6K and mTOR: Findings from 3-D melanoma skin equivalents and computational modeling
Deeba N. Syed et al.
BIOCHEMICAL PHARMACOLOGY (2014)
The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration
David Heras-Sandoval et al.
CELLULAR SIGNALLING (2014)
Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB
Vinicia A. Polito et al.
EMBO MOLECULAR MEDICINE (2014)
Regulatory Effects of Fisetin on Microglial Activation
Jing-Yuan Chuang et al.
MOLECULES (2014)
Role of Nrf2 in Oxidative Stress and Toxicity
Qiang Ma
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013 (2013)
Concurrent regulation of the transcription factors Nrf2 and ATF4 mediates the enhancement of glutathione levels by the flavonoid fisetin
Jennifer L. Ehren et al.
BIOCHEMICAL PHARMACOLOGY (2013)
mTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6
Francesca Nazio et al.
NATURE CELL BIOLOGY (2013)
Dietary flavonoid fisetin: A novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management
Vaqar Mustafa Adhami et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Tau-targeted treatment strategies in Alzheimer's disease
Juergen Goetz et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB
Carmine Settembre et al.
EMBO JOURNAL (2012)
Autophagic degradation of tau in primary neurons and its enhancement by trehalose
Ulrike Krueger et al.
NEUROBIOLOGY OF AGING (2012)
The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics
Susanne M. Pritchard et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Suppression of Autophagy and Activation of Glycogen Synthase Kinase 3beta Facilitate the Aggregate Formation of Tau
Song-In Kim et al.
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2011)
Amyloid-β and tau - a toxic pas de deux in Alzheimer's disease
Lars M. Ittner et al.
NATURE REVIEWS NEUROSCIENCE (2011)
TFEB Links Autophagy to Lysosomal Biogenesis
Carmine Settembre et al.
SCIENCE (2011)
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Lars M. Ittner et al.
CELL (2010)
Methods in Mammalian Autophagy Research
Noboru Mizushima et al.
CELL (2010)
Tau in Alzheimer Disease and Related Tauopathies
K. Iqbal et al.
CURRENT ALZHEIMER RESEARCH (2010)
A Caspase Cleaved Form of Tau Is Preferentially Degraded through the Autophagy Pathway
Philip J. Dolan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
p62/SQSTM1 Is a Target Gene for Transcription Factor NRF2 and Creates a Positive Feedback Loop by Inducing Antioxidant Response Element-driven Gene Transcription
Ashish Jain et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
MECHANISMS OF DISEASE Alzheimer's Disease
Henry W. Querfurth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Alzheimer's Disease: From Pathology to Therapeutic Approaches
Roland Jakob-Roetne et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Autophagic-lysosomal perturbation enhances tau aggregation in transfectants with induced wild-type tau expression
Tadanori Hamano et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Suppressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity
Long Tai Zheng et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2008)
Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration
J. Ramesh Babu et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model
Erik D. Roberson et al.
SCIENCE (2007)
Tau-mediated neurodegeneration in Alzheimer's disease and related disorders
Carlo Ballatore et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory
Pamela Maher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Upstream of the mammalian target of rapamycin: do all roads pass through mTOR?
M. N. Corradetti et al.
ONCOGENE (2006)
Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation
F Liu et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Induction of PC12 cell differentiation by flavonoids is dependent upon extracellular signal-regulated kinase activation
Y Sagara et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Glycogen synthase kinase 3β induces caspase-cleaved tau aggregation in situ
JH Cho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease
P Giannakopoulos et al.
NEUROLOGY (2003)
Tau is essential to β-amyloid-induced neurotoxicity
M Rapoport et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms
K Ishige et al.
FREE RADICAL BIOLOGY AND MEDICINE (2001)
Share Paper
